top of page

EC approves Opdivo + Yervoy regimen for advanced melanoma

The European Commission (EC) has approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy for the treatment of advanced (unresectable or metastatic) melanoma in adults.

Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/41062/news/industry-news/opdivo-yervoy-advanced-melanoma/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page